|
Racial disparities in prostate cancer incidence rates by census division in the United States, 1999-2008
|
Research Initiative
|
CDC
|
NCI
|
An analysis of the National Program of Cancer Registries database to assess census division differences by race (white, black) in trends of prostate cancer.
|
|
Radiation Biodosimetry Working Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIAID
|
This working group is focused on regulatory and scientific issues regarding technologies and devices for radiation biodosimetry. The working group assisted in drafting new Food and Drug Administration (FDA) Center for Device and Radiological Health (CDRH) guidance for industry.
|
|
Radiation Emergency Medical Management (REMM)
|
Resource Development
|
CDC, OS
|
NLM, NCI
|
This activity is to develop a comprehensive web resource. Radiation Emergency Medical Management (REMM) is a mechanism to collect, evaluate, collate, store and make available electronically to health care professionals immediate, up-to-date, evidence-based clinical information they would use to treat civilian patients and others affected by radiation incidents.
|
|
Radiation/Nuclear Biodosimetry Team
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NIAID
|
Team members participate in the review of white papers as well as proposals and progress reviews for Biomedical Advanced Research and Development Authority (BARDA)-funded contracts supporting the development of novel biodosimetry platforms.
|
|
Radiation/Nuclear Technical Evaluation Review Panel
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NIAID
|
The National Institute of Allergy and Infectious Diseases (NIAID) participates on the Radiation/Nuclear Technical Evaluation Review Panel to review white papers and proposals received by the U.S. Department of Health and Human Services (HHS) Biomedical Advanced Research and Development Authority (BARDA) for the development of radiation nuclear medical countermeasures. NIAID provides scientific and programmatic critiques and reviews of selected submissions.
|
|
Radiobiology Bioterrorism Research and Training Group (RABRAT)
|
Meeting/ Workshop
|
FDA, OS
|
NCI
|
This activity involves monthly meetings to discuss research initiatives, funding opportunities, training, conferences, publications and other events and information related to preparing the U.S. Government to respond to nuclear terrorism.
|
|
Randomized Intervention in Children with Vesicoureteral Reflux (RIVUR)
|
Research Initiative
|
OS
|
NIDDK
|
The multicenter, randomized, double-blind, placebo-controlled Randomized Intervention in Children with Vesicoureteral Reflux (RIVUR) trial is designed to determine whether daily antimicrobial prophylaxis is superior to placebo in preventing recurrence of urinary tract infection (UTI) in children with vesicoureteral reflux (VUR). The study is designed to recruit 600 children (approximately 300 in each treatment group) over an 18-24 month period. The primary endpoint is recurrence of UTI. Quality of life, compliance, safety parameters, utilization of health resources, and change in VUR will be assessed periodically throughout the study.
|
|
Reciprocal Educational and Training Partnerships between FDA/CDER and the NIH Clinical Center
|
Training Initiative
|
FDA
|
CC, NCI, NIAID, NIDCR, NIDDK, NIMH, NINDS
|
This activity is sponsored by the Clinical Pharmacology Program, Office of Clinical Research Training and Medical Education (OCRTME) at The National Institutes of Health (NIH) Clinical Center (CC) and it consists of elective rotations at the Office of Clinical Pharmacology (OCP) and the Office of New Drugs (OND) of the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research for NIH staff with a primary focus on clinical fellows and research fellows who expressed an interest in learning more about FDA regulatory sciences applicable to drug development research. Rotating fellows are mentored by FDA staff on the required elements of an Investigational New Drug (IND) application and the key elements of the FDA review process from a regulatory perspective. This program also established a mechanism for FDA scientific reviewers at the OCP to rotate at the NIH CC and to interact with members of a clinical research team, thus acquiring a better perspective on clinical research protocol implementation and the requirements of an Institutional Review Board (IRB) at the NIH.
|
|
Reentry Research Network
|
Committee, Work group, Advisory group, or Task Force
|
ACF, SAMHSA
|
NIDA, OD/DPCPSI/OBSSR
|
This is a subgroup that reports to the Federal Interagency Reentry Council. The purpose of this group is to bring together numerous federal agencies to make communities safer, assist those returning from prison and jail to becoming productive, tax-paying citizens, and save taxpayer dollars by lowering the direct and collateral costs of incarceration.
|
|
Regional Grant Writing and Scientific Peer Review Workshop
|
Meeting/ Workshop
|
CDC
|
NCI, CSR, FIC, NHLBI, NIAID, NICHD, NIDA, NIMH, NINDS, OD/DPCPSI/OAR, OD/DPCPSI/ODP
|
The Center for Global Health of the U.S. National Cancer Institute (NCI) in collaboration with the South African Medical Research Council (SAMRC) will hold regional grant writing and peer review workshops to encourage investigators to address public health issues through research. The objectives of the workshops are to (1) increase the participation of scientists from mid- to low-resource countries in the research grant process; (2) develop strategies for sustainable research support and collaborations, and; (3) use competitive research as a tool to address global health issues.
|